Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Bioinformatic Study of the Active Compound of Morusin in Mulberry (Morus alba) against Breast Cancer

Indonesian Journal of Cancer Chemoprevention · Vol. 14 No. 1 (2023) · hlm. 60–71

DOI
10.14499/indonesianjcanchemoprev14iss1pp60-71
ISSN
2355-8989, 2088-0197
Terbit
2023-02-28
Penerbit
Indonesian Society for Cancer Chemoprevention
Bahasa
eng

Abstrak

Morusin, an active constituent of the mulberry plant (Morus alba), exhibits inhibitory effects on several types of cancer cells in vitro, including breast cancer. This study aimed to identify potential target proteins of morusin, investigate the binding energy, and explore type of interactions between morusin and the target protein. Morusin target was searched using the PubMed, STITCH, STRING, and Cytoscape databases. Subsequently, the obtained morusin target protein data underwent processing using Autodock Tools and DS BIOVIA to facilate the simulation of molecular docking between morusin and the target protein. The study identified EGFR, SRC, and MAPK1 as potential targets for morusin. Docking simulations revealed that both EGFR and SRC represent viable targets for morusin, as their binding energies were lower than those of the native ligand and lapatinib. Specifically, the bond energies at EGFR were -9.6, -7.5, and -9.2 kcal/mol for morusin, the native ligand, and lapatinib, respectively. Similarly, at SRC, the corresponding bond energies were -8.2, -6.4, and -5.3 kcal/mol. Morusin demonstrated binding interactions with Leu694, Val702, Leu820, Ala719, Leu768, and Lys721 at the active site of EGFR, and with Lys295 and Gly344 at the binding active sites of SRC. Consequently, morusin has the potential to suppress cancer cell growth by targeting EGFR and SRC.Keywords: cancer cells, EGFR and SRC as targets, molecular docking, morusin, mulberry plant.

Jaringan kolaborasi para penulis

40 penulis · 165 tautan kepenulisan bersama · 47 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Sumatera Institute of Technology
  • Jenderal Soedirman University
  • Universitas Gadjah Mada
  • Universitas Jember
  • Bandung Institute of Technology
  • Muhammadiyah University of Yogyakarta
  • Politeknik Kesehatan Bhakti Setya Indonesia
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Muhamad Salman FarezaJenderal Soedirman University4
Dyaningtyas Dewi Pamungkas PutriUniversitas Gadjah Mada3
Edy MeiyantoUniversitas Gadjah Mada2
Anindyajati AnindyajatiUniversitas Gadjah Mada2
Nisa Yulianti SuprahmanSumatera Institute of Technology2
Endah PuspitasariUniversitas Jember2
Faculty of Science, Institut Teknologi Sumatera, South Lampung 35365, Indonesia Department of PharmacyAfiliasi tidak diketahui2
Faculty of Health Sciences, Universitas Jenderal Soedirman, Purwokerto, Indonesia Department of PharmacyAfiliasi tidak diketahui2
Jenderal Soedirman University, Purwokerto 53123, Indonesia Department of PharmacyAfiliasi tidak diketahui2
Raymond DevaraJenderal Soedirman University2
Arif FadlanInstitut Teknologi Sepuluh Nopember2
Dicky Rizky FebrianJenderal Soedirman University2
Joko SetyonoJenderal Soedirman University2
Triyadi Hendra WijayaJenderal Soedirman University2
Hendri WasitoJenderal Soedirman University2
Tuti Sri SuhestiJenderal Soedirman University2
Genta Hafied Naga SamudraJenderal Soedirman University2
Syahdan AsradaJenderal Soedirman University2
Dafi FischellyaJenderal Soedirman University2
Adam HermawanUniversitas Gadjah Mada1
Sukrasno SukrasnoBandung Institute of Technology1
Winni Nur AuliSumatera Institute of Technology1
Riri FauziyyaSumatera Institute of Technology1
Arif AshariSumatera Institute of Technology1
Kalista AlsadilaSumatera Institute of Technology1
Lanita AgustinSumatera Institute of Technology1
Safia FazilaSumatera Institute of Technology1
Miralda ZahraSumatera Institute of Technology1
Esteria Christina PaneSumatera Institute of Technology1
Rifki FebriansahMuhammadiyah University of Yogyakarta1
Nur IsmiyatiPoliteknik Kesehatan Bhakti Setya Indonesia1
Aditya FitriasariUniversitas Gadjah Mada1
Ahmad Zammi Autadan HakimSumatera Institute of Technology1
Refsya Azanti PutriSumatera Institute of Technology1
Dzaky Raihan CahyadiSumatera Institute of Technology1
Muhammad Yogi SaputraSumatera Institute of Technology1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ijcc.chemoprev.org/index.php/ijcc/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Bioinformatic Study of the Active Compound of Morusin in Mulberry (Morus alba) against Breast Cancer</dc:title>
	<dc:creator>Sarmoko, Sarmoko</dc:creator>
	<dc:creator>Pratama, Afif Hariawan</dc:creator>
	<dc:creator>Choironi, Nur Amalia</dc:creator>
	<dc:creator>Fareza, Muhammad Salman</dc:creator>
	<dc:description xml:lang="en-US">Morusin, an active constituent of the mulberry plant (Morus alba), exhibits inhibitory effects on several types of cancer cells in vitro, including breast cancer. This study aimed to identify potential target proteins of morusin, investigate the binding energy, and explore type of interactions between morusin and the target protein. Morusin target was searched using the PubMed, STITCH, STRING, and Cytoscape databases. Subsequently, the obtained morusin target protein data underwent processing using Autodock Tools and DS BIOVIA to facilate the simulation of molecular docking between morusin and the target protein. The study identified EGFR, SRC, and MAPK1 as potential targets for morusin. Docking simulations revealed that both EGFR and SRC represent viable targets for morusin, as their binding energies were lower than those of the native ligand and lapatinib. Specifically, the bond energies at EGFR were -9.6, -7.5, and -9.2 kcal/mol for morusin, the native ligand, and lapatinib, respectively. Similarly, at SRC, the corresponding bond energies were -8.2, -6.4, and -5.3 kcal/mol. Morusin demonstrated binding interactions with Leu694, Val702, Leu820, Ala719, Leu768, and Lys721 at the active site of EGFR, and with Lys295 and Gly344 at the binding active sites of SRC. Consequently, morusin has the potential to suppress cancer cell growth by targeting EGFR and SRC.Keywords: cancer cells, EGFR and SRC as targets, molecular docking, morusin, mulberry plant.</dc:description>
	<dc:publisher xml:lang="en-US">Indonesian Society for Cancer Chemoprevention</dc:publisher>
	<dc:contributor xml:lang="en-US">Jenderal Soedirman University</dc:contributor>
	<dc:date>2023-02-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijcc.chemoprev.org/index.php/ijcc/article/view/457</dc:identifier>
	<dc:identifier>10.14499/indonesianjcanchemoprev14iss1pp60-71</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Cancer Chemoprevention; Vol 14, No 1 (2023); 60-71</dc:source>
	<dc:source>2355-8989</dc:source>
	<dc:source>2088-0197</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijcc.chemoprev.org/index.php/ijcc/article/view/457/276</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Sarmoko Sarmoko, Afif Hariawan Pratama, Nur Amalia Choironi, Muhammad Salman Fareza</dc:rights>
</oai_dc:dc>